International Assets Investment Management’s GSK GSK Stock Holding History

International Assets Investment Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-226,487	Closed	-$5.54K	–	1232
2024 Q3	$5.54K	Buy	226,487 +220,952	+3,992%	+$9.04M	0.02%	548
2024 Q2	$213K	Buy	5,535 +327	+6%	+$13.8K	0.02%	682
2024 Q1	$221K	Buy	+5,208	New	+$215K	0.02%	643
2023 Q1	–	Sell	-12,199	Closed	-$429K	–	1238
2022 Q4	$429K	Buy	+12,199	New	+$406K	0.04%	379
2021 Q4	–	Sell	-6,975	Closed	-$333K	–	544
2021 Q3	$333K	Sell	6,975 -1,013	-13%	-$50.9K	0.06%	317
2021 Q2	$398K	Buy	7,988 +4,037	+102%	+$194K	0.07%	273
2021 Q1	$182K	Hold	3,951	–	–	0.02%	536
2020 Q4	$182K	Buy	+3,951	New	+$181K	0.03%	401
2020 Q2	–	Sell	-4,692	Closed	-$222K	–	419
2020 Q1	$222K	Buy	+4,692	New	+$250K	0.07%	252

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

International Assets Investment Management's GSK Position: Q4 2024 in Review

International Assets Investment Management sold out of GSK (GSK) in Q4 2024, closing a stake of 226,487 shares — an estimated $5.54K sold.

International Assets Investment Management first reported a position in GSK in Q1 2020 and held it in 9 quarters. The position peaked at $429K in Q4 2022. 849 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

International Assets Investment Management reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
International Assets Investment Management sold 226,487 GSK shares in Q4 2024, an estimated $5.54K.
International Assets Investment Management first reported a position in GSK in Q1 2020 and held it in 9 quarters.
International Assets Investment Management's GSK position peaked at $429K in Q4 2022.
849 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on International Assets Investment Management's 13F filing for Q4 2024, filed 8 Jan 2025.